{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:14:02Z","timestamp":1776384842517,"version":"3.51.2"},"reference-count":168,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011566","name":"Sidney Kimmel Comprehensive Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002135","name":"Hirshberg Foundation for Pancreatic Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002135","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA112314"],"award-info":[{"award-number":["R01 CA112314"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017062","name":"Johns Hopkins Hospital","doi-asserted-by":"publisher","award":["P30 CA006973"],"award-info":[{"award-number":["P30 CA006973"]}],"id":[{"id":"10.13039\/100017062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017062","name":"Johns Hopkins Hospital","doi-asserted-by":"publisher","award":["numberP30 CA006973"],"award-info":[{"award-number":["numberP30 CA006973"]}],"id":[{"id":"10.13039\/100017062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jbc.2026.111243","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:48:41Z","timestamp":1770252521000},"page":"111243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Profiling the pancreatic cancer secretome with metabolic glycoengineering"],"prefix":"10.1016","volume":"302","author":[{"given":"Kris","family":"Dammen-Brower","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Agatemor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safiya","family":"Aafreen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vrinda","family":"Dharharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher T.","family":"Saeui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3826-0735","authenticated-orcid":false,"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Buettner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith R.","family":"Kwagala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3190-2475","authenticated-orcid":false,"given":"Howard E.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanshu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4279-1459","authenticated-orcid":false,"given":"Kevin J.","family":"Yarema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.111243_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/030089160108700513","article-title":"Extraordinarily elevated CA19-9 in benign conditions: a case report and review of the literature","volume":"87","author":"Akdo\u011fran","year":"2001","journal-title":"Tumori"},{"key":"10.1016\/j.jbc.2026.111243_bib2","article-title":"Identification of novel early pancreatic cancer biomarkers KIF5B and SFRP2 from \u201cfirst contact\u201d interactions in the tumor microenvironment","volume":"41","author":"Jacob","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2026.111243_bib3","first-page":"105","article-title":"The clinical utility of serum CA 19-9 in the diagnosis, prognosis and clinical management of pancreatic adenocarcinoma: an evidence based approach","volume":"3","author":"Ballehaninna","year":"2012","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.jbc.2026.111243_bib4","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1515\/cclm-2017-0001","article-title":"Extraordinarily elevated serum CA19-9 in a patient with posterior mediastinum cyst: a case report","volume":"55","author":"Chen","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jbc.2026.111243_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.21037\/amj.2017.02.02","article-title":"An extremely increased CA19-9 level due to common bile duct stone: a case report","volume":"2","author":"Wang","year":"2017","journal-title":"AME Med. .l"},{"key":"10.1016\/j.jbc.2026.111243_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijscr.2018.11.022","article-title":"Dilemmas and limitations interpreting carbohydrate antigen 19-9 elevation after curative pancreatic durgery: a vase report","volume":"54","author":"Gold","year":"2019","journal-title":"Int. J. Surg. Case Rep."},{"key":"10.1016\/j.jbc.2026.111243_bib7","first-page":"7","article-title":"Cancer statistics","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jbc.2026.111243_bib8","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/0046-8177(90)90250-9","article-title":"Cancer-associated carbohydrates identified by monoclonal antibodies","volume":"21","author":"Sell","year":"1990","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jbc.2026.111243_bib9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1023\/A:1018580324971","article-title":"Perspectives on the significance of altered glycosylation of glycoproteins in cancer","volume":"14","author":"Kim","year":"1997","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.jbc.2026.111243_bib10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrd1751","article-title":"Glycans in cancer and inflammation--potential for therapeutics and diagnostics","volume":"4","author":"Dube","year":"2005","journal-title":"Nat. Rev. Drug Disc"},{"key":"10.1016\/j.jbc.2026.111243_bib11","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrc1649","article-title":"The sweet and sour of cancer: glycans as novel therapeutic targets","volume":"5","author":"Fuster","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2026.111243_bib12","doi-asserted-by":"crossref","first-page":"11R","DOI":"10.1093\/glycob\/11.2.11R","article-title":"Biochemical engineering of the N-acyl side chain of sialic acid: biological implications","volume":"11","author":"Keppler","year":"2001","journal-title":"Glycobiology"},{"key":"10.1016\/j.jbc.2026.111243_bib13","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.cell.2006.08.017","article-title":"Chemical technologies for probing glycans","volume":"126","author":"Prescher","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.111243_bib14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1039\/B614939C","article-title":"Metabolic oligosaccharide engineering: perspectives, applications, and future directions","volume":"3","author":"Campbell","year":"2007","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.jbc.2026.111243_bib15","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/glycob\/cwp115","article-title":"Metabolic glycoengineering: sialic acid and beyond","volume":"19","author":"Du","year":"2009","journal-title":"Glycobiology"},{"key":"10.1016\/j.jbc.2026.111243_bib16","doi-asserted-by":"crossref","first-page":"9482","DOI":"10.1002\/anie.201601123","article-title":"Metabolic glycoengineering with N-acyl side chain modified mannosamines","volume":"55","author":"Wratil","year":"2016","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jbc.2026.111243_bib17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41570-019-0126-y","article-title":"Exploiting metabolic glycoengineering to advance healthcare","volume":"3","author":"Agatemor","year":"2019","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.jbc.2026.111243_bib18","series-title":"Chemistry, Molecular Sciences and Chemical Engineering (Barchi J Jr Ed.)","article-title":"Imaging glycans with metabolic glycoengineering","author":"Agatemor","year":"2020"},{"key":"10.1016\/j.jbc.2026.111243_bib19","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1126\/science.276.5315.1125","article-title":"Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis","volume":"276","author":"Mahal","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.111243_bib20","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1021\/ja984228m","article-title":"Exploiting differences in sialoside expression for selective targeting of MRI contrast reagents","volume":"121","author":"Lemieux","year":"1999","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2026.111243_bib21","doi-asserted-by":"crossref","first-page":"8563","DOI":"10.1021\/ja101766r","article-title":"Real-time bioluminescence imaging of glycans on live cells","volume":"132","author":"Cohen","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2026.111243_bib22","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1096\/fj.10-178590","article-title":"Imaging sialylated tumor cell glycans in vivo","volume":"25","author":"Neves","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.jbc.2026.111243_bib23","doi-asserted-by":"crossref","first-page":"14918","DOI":"10.1002\/ange.201608504","article-title":"Cathepsin B-specific metabolic precursor for in vivo tumor-specific fluorescence imaging","volume":"55","author":"Shim","year":"2016","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jbc.2026.111243_bib24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nchembio.2297","article-title":"Selective in vivo metabolic cell-labeling-mediated cancer targeting","volume":"13","author":"Wang","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111243_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119305","article-title":"In vivo cancer targeting via glycopolyester nanoparticle mediated metabolic cell labeling followed by click reaction","volume":"218","author":"Wang","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jbc.2026.111243_bib26","article-title":"Bio-orthogonal T cell targeting strategy for robustly enhancing cytotoxicity against tumor cells","volume":"15","author":"Li","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.jbc.2026.111243_bib27","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1038\/emboj.2012.173","article-title":"Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons","volume":"31","author":"Kuhn","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2026.111243_bib28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/prca.201300006","article-title":"Targeted glycoprotein enrichment and identification in stromal cell secretomes using azido sugar metabolic labeling","volume":"7","author":"Roper","year":"2013","journal-title":"Proteom. Clin. Appl."},{"key":"10.1016\/j.jbc.2026.111243_bib29","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1021\/pr8008572","article-title":"Pathway-based biomarker search by high-throughput proteomics profiling of secretomes","volume":"8","author":"Lawlor","year":"2009","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jbc.2026.111243_bib30","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1074\/mcp.M900134-MCP200","article-title":"Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines","volume":"8","author":"Planque","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jbc.2026.111243_bib31","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.copbio.2010.06.004","article-title":"Pathways of unconventional protein secretion","volume":"21","author":"Nickel","year":"2010","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jbc.2026.111243_bib32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1586\/epr.12.21","article-title":"Advances in the proteomic investigation of the cell secretome","volume":"9","author":"Brown","year":"2012","journal-title":"Exp. Rev. Proteomics"},{"key":"10.1016\/j.jbc.2026.111243_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaz0274","article-title":"The human secretome","volume":"12","author":"Uhl\u00e9n","year":"2019","journal-title":"Sci. Signal"},{"key":"10.1016\/j.jbc.2026.111243_bib34","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.imlet.2006.09.005","article-title":"Exosomes: from biogenesis and secretion to biological function","volume":"107","author":"Keller","year":"2006","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jbc.2026.111243_bib35","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.bbapap.2013.04.005","article-title":"Blood\/plasma secretome and microvesicles","volume":"1834","author":"Inal","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2026.111243_bib36","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/hep.30701","article-title":"Exosomal transport of hepatocyte-derived drug-modified proteins to the immune system","volume":"70","author":"Ogese","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jbc.2026.111243_bib37","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1080\/15384047.2015.1071740","article-title":"Bioorthogonal labeling cell-surface proteins expressed in pancreatic cancer cells to identify potential diagnostic\/therapeutic biomarkers","volume":"16","author":"Haun","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.jbc.2026.111243_bib38","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.biomaterials.2016.11.044","article-title":"Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example","volume":"116","author":"Badr","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jbc.2026.111243_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2026.111243_bib40","doi-asserted-by":"crossref","first-page":"10202","DOI":"10.1073\/pnas.1704961114","article-title":"Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers","volume":"114","author":"Cohen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S .A"},{"key":"10.1016\/j.jbc.2026.111243_bib41","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.111243_bib42","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1021\/cb7002708","article-title":"Regioisomeric SCFA attachment to hexosamines separates metabolic flux from cytotoxicity and MUC1 suppression","volume":"3","author":"Aich","year":"2008","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111243_bib43","series-title":"Glycoscience","first-page":"2133","article-title":"Non-natural sugar analogues: chemical probes for metabolic oligosaccharide engineering","author":"Aich","year":"2008"},{"key":"10.1016\/j.jbc.2026.111243_bib44","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.cbpa.2009.08.001","article-title":"Hexosamine analogs: from metabolic glycoengineering to drug discovery","volume":"13","author":"Wang","year":"2009","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111243_bib45","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M112.017558","article-title":"Metabolic flux increases glycoprotein sialylation: implications for cell adhesion and cancer metastasis","volume":"11","author":"Almaraz","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jbc.2026.111243_bib46","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/bit.24363","article-title":"Metabolic oligosaccharide engineering with N-acyl functionalized ManNAc analogues: cytotoxicity, metabolic flux, and glycan-display considerations","volume":"109","author":"Almaraz","year":"2012","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jbc.2026.111243_bib47","doi-asserted-by":"crossref","first-page":"16793","DOI":"10.1073\/pnas.0707090104","article-title":"Copper-free click chemistry for dynamic in vivo imaging","volume":"104","author":"Baskin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111243_bib48","first-page":"2253","article-title":"Visualizing metabolically labeled glycoconjugates of living cells by copper-free and fast Huisgen cycloadditions","volume":"47","author":"Ning","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jbc.2026.111243_bib49","doi-asserted-by":"crossref","first-page":"11486","DOI":"10.1021\/ja803086r","article-title":"Second-generation difluorinated cyclooctynes for copper-free click chemistry","volume":"130","author":"Codelli","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2026.111243_bib50","doi-asserted-by":"crossref","DOI":"10.1186\/s12014-015-9083-8","article-title":"Identification of sialylated glycoproteins from metabolically oligosaccharide engineered pancreatic cells","volume":"12","author":"Tian","year":"2015","journal-title":"Clin. Proteomics"},{"key":"10.1016\/j.jbc.2026.111243_bib51","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1053\/ejso.1999.0925","article-title":"Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice","volume":"26","author":"Mann","year":"2000","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.jbc.2026.111243_bib52","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1365-2559.2002.01374.x","article-title":"Immunohistochemical localizations of CEA, CA19-9 and DU-PAN-2 in hepatitis C virus-infected liver tissue","volume":"40","author":"Kitagawa","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.jbc.2026.111243_bib53","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1080\/00365521.2017.1322140","article-title":"Multicystic biliary hamartoma with extremely elevated CA19-9: a case report","volume":"52","author":"Morinaga","year":"2017","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jbc.2026.111243_bib54","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1126\/science.287.5460.2007","article-title":"Cell surface engineering by a modified Staudinger reaction","volume":"287","author":"Saxon","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.111243_bib55","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.bmcl.2015.01.060","article-title":"Metabolic glycoengineering sensitizes drug-resistant pancreatic cancer cells to tyrosine kinase inhibitors erlotinib and gefitinib","volume":"25","author":"Mathew","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jbc.2026.111243_bib56","series-title":"Cell Engineering 3. Glycosylation","first-page":"171","article-title":"A metabolic substrate-based approach to engineering new chemical reactivity into cellular sialoglycoconjugates","author":"Yarema","year":"2002"},{"key":"10.1016\/j.jbc.2026.111243_bib57","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1016\/j.bmcl.2012.09.017","article-title":"Extracellular and intracellular esterase processing of SCFA-hexosamine analogs: implications for metabolic glycoengineering and drug delivery","volume":"22","author":"Mathew","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jbc.2026.111243_bib58","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/bit.10901","article-title":"Characterization of the cellular uptake and metabolic conversion of acetylated N-acetylmannosamine (ManNAc) analogues to sialic acids","volume":"85","author":"Jones","year":"2004","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jbc.2026.111243_bib59","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/cas.12627","article-title":"Increased sialidase activity in serum of cancer patients: identification of sialidase and inhibitor activities in human serum","volume":"106","author":"Hata","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jbc.2026.111243_bib60","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10719-018-9820-0","article-title":"Serum sialylation changes in cancer","volume":"35","author":"Zhang","year":"2018","journal-title":"Glycoconj J."},{"key":"10.1016\/j.jbc.2026.111243_bib61","doi-asserted-by":"crossref","first-page":"31168","DOI":"10.1074\/jbc.273.47.31168","article-title":"Metabolic delivery of ketone groups to sialic acid residues. Application to cell surface glycoform engineering","volume":"273","author":"Yarema","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111243_bib62","series-title":"Glycosylation changes in cancer, Essentials of Glycobiology","author":"Varki","year":"2009"},{"key":"10.1016\/j.jbc.2026.111243_bib63","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1158\/0008-5472.CAN-14-0728","article-title":"Sialic acids sweeten a tumor's life","volume":"74","author":"B\u00fcll","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111243_bib64","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc3982","article-title":"Glycosylation in cancer: mechanisms and clinical implications","volume":"15","author":"Pinho","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2026.111243_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174248","article-title":"Aberrant sialylation in cancer: therapeutic opportunities","volume":"14","author":"Munkley","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jbc.2026.111243_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195812","article-title":"Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes","volume":"13","author":"Saeui","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.111243_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.00013","article-title":"Cell line-, protein-, and sialoglycosite-specific control of flux-based sialylation in human breast cells: implications for cancer progression","volume":"8","author":"Saeui","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.jbc.2026.111243_bib68","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1073\/pnas.0811481106","article-title":"Imaging the glycome","volume":"106","author":"Laughlin","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111243_bib69","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1074\/jbc.M110.171322","article-title":"Sialic acids attached to O-glycans modulate voltage-gated potassium channel gating","volume":"286","author":"Schwetz","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111243_bib70","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/anie.201711710","article-title":"Artificial cysteine S-glycosylation induced by per-O-acetylated unnatural monosaccharides during metabolic glycan labeling","volume":"57","author":"Qin","year":"2018","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jbc.2026.111243_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11942-y","article-title":"Next-generation unnatural monosaccharides reveal that ESRRB O-GlcNAcylation regulates pluripotency of mouse embryonic stem cells","volume":"10","author":"Hao","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111243_bib72","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/onc.2017.303","article-title":"Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation","volume":"37","author":"Chiang","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.111243_bib73","doi-asserted-by":"crossref","first-page":"457","DOI":"10.21037\/tau.2019.09.02","article-title":"Carcinoembryonic antigen related cell adhesion molecule 6 promotes the proliferation and migration of renal cancer cells through the ERK\/AKT signaling pathway","volume":"8","author":"Zhu","year":"2019","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.jbc.2026.111243_bib74","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1158\/1541-7786.MCR-08-0095","article-title":"Mesothelin-induced pancreatic cancer cell proliferation involves alteration of cyclin E via activation of signal transducer and activator of transcription protein 3","volume":"6","author":"Bharadwaj","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jbc.2026.111243_bib75","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/hpb.12199","article-title":"Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer","volume":"16","author":"Kendrick","year":"2014","journal-title":"HPB"},{"key":"10.1016\/j.jbc.2026.111243_bib76","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/1878-0261.12768","article-title":"Aberrantly elevated suprbasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes","volume":"10","author":"Pribyl","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.jbc.2026.111243_bib77","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41416-022-01794-7","article-title":"SBSN drives bladder cancer metastasis via EGFR\/SRC\/STAT3 signalling","volume":"127","author":"Zhou","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbc.2026.111243_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.810681","article-title":"Role of suprabasin in the dedifferentiation of follicular epithelial cell-derived thyroid cancer and identification of related immune markers","volume":"13","author":"Tan","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.jbc.2026.111243_bib79","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/genes12010108","article-title":"Suprabasin - a review","volume":"12","author":"Pribyl","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.jbc.2026.111243_bib80","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s11033-021-06897-7","article-title":"Suprabasin: role in human cancers and other diseases","volume":"49","author":"Tan","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jbc.2026.111243_bib81","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1021\/pr5008703","article-title":"Quantitative proteomic analysis of exosome protein content changes induced by hepatitis B virus in Huh-7 cells using SILAC labeling and LC-MS\/MS","volume":"13","author":"Zhao","year":"2014","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jbc.2026.111243_bib82","doi-asserted-by":"crossref","first-page":"15375","DOI":"10.18632\/oncotarget.3801","article-title":"Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes","volume":"6","author":"Keerthikumar","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2026.111243_bib83","first-page":"4247","article-title":"Overexpression of FAM3C protein as a novel biomarker for epithelial-mesenchymal transition and poor outcome in gastric cancer","volume":"11","author":"Yin","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.jbc.2026.111243_bib84","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-42060-x","article-title":"FAM3 family genes are associated with prognostic value of human cancer: a pan-cancer analysis","volume":"13","author":"Dong","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.111243_bib85","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1158\/0008-5472.CAN-23-1641","article-title":"FAM3C in cancer-associated adipocytes promotes breast cancer cell survival and metastasis","volume":"84","author":"Kim","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111243_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073936","article-title":"Glycoproteomic and phenotypic elucidation of B4GALNT2 expression variants in the SID histo-blood group system","volume":"23","author":"Stenfelt","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.111243_bib87","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgac242","article-title":"Human FAM3C restores memory-based thermotaxis of caenorhabditis elegans famp-1\/m70.4 loss-of-function mutants","volume":"1","author":"Nakano","year":"2022","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.jbc.2026.111243_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Huang","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111243_bib89","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jbc.2026.111243_bib90","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1172\/JCI90962","article-title":"The role of the complement system in cancer","volume":"127","author":"Afshar-Kharghan","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2026.111243_bib91","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-019-1027-3","article-title":"Role of the complement system in the tumor microenvironment","volume":"19","author":"Zhang","year":"2019","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.jbc.2026.111243_bib92","article-title":"Complement in pancreatic disease - perpetrator or savior?","volume":"8","author":"Huber-Lang","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2026.111243_bib93","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.1073\/pnas.1812410116","article-title":"Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion","volume":"116","author":"Elliott","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111243_bib94","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2019-4593","article-title":"Inhibition of invasion of HER2-positive breast cancer cells by lysosome targeting drugs","volume":"79","author":"Hansen","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111243_bib95","doi-asserted-by":"crossref","first-page":"16862","DOI":"10.1074\/jbc.272.27.16862","article-title":"Effect of saposins A and C on the enzymatic hydrolysis of liposomal glucosylceramide","volume":"272","author":"Vaccaro","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111243_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020475","article-title":"Are glucosylceramide-related sphingolipids involved in the increased risk for cancer in Gaucher disease patients? Review and hypotheses","volume":"12","author":"Dubot","year":"2020","journal-title":"Cancer (Basel)"},{"key":"10.1016\/j.jbc.2026.111243_bib97","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"32","author":"Jones","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.111243_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41523-019-0105-y","article-title":"AKT1low quiescent cancer cells in ductal carcinoma in situ of the breast","volume":"5","author":"Kabraji","year":"2019","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.jbc.2026.111243_bib99","first-page":"4130","article-title":"Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII","volume":"57","author":"Wikstrand","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111243_bib100","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0959-8049(01)00231-3","article-title":"EGFR and cancer prognosis","volume":"37","author":"Nicholson","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jbc.2026.111243_bib101","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.tranon.2018.08.021","article-title":"Therapeutic targeting cancer-initiating cell markers by exosome MiRNA: efficacy and functional consequences exemplified for Claudin7 and EpCAM","volume":"12","author":"Kyuno","year":"2019","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.jbc.2026.111243_bib102","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejca.2019.09.024","article-title":"Comprehensive analysis of colorectal cancer-risk loci and survival outcome: a prognostic role for CDH1 variants","volume":"124","author":"Summers","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jbc.2026.111243_bib103","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.4161\/cc.4.11.2129","article-title":"Oncogenic \u03b2-catenin signaling networks in colorectal cancer","volume":"4","author":"Fuchs","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jbc.2026.111243_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030516","article-title":"Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism","volume":"3","author":"Pogue-Geile","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.jbc.2026.111243_bib105","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4161\/cbt.6.3.3904","article-title":"Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells","volume":"6","author":"Salaria","year":"2007","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.jbc.2026.111243_bib106","article-title":"Expression of human dCTP pyrophosphatase 1 (DCTPP1) and its association with cisplatin resistance characteristics in ovarian cancer","volume":"28","author":"Wang","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jbc.2026.111243_bib107","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41556-021-00693-y","article-title":"Quantitative proteomics identifies the core proteome of exosomes with syntenin-1 as the highest abundant protein and a putative universal biomarker","volume":"23","author":"Kugeratski","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111243_bib108","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.4161\/cc.6390","article-title":"Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells","volume":"7","author":"Mannava","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jbc.2026.111243_bib109","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.gde.2009.01.002","article-title":"The molecular determinants of de novo nucleotide biosynthesis in cancer cells","volume":"19","author":"Tong","year":"2009","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.jbc.2026.111243_bib110","doi-asserted-by":"crossref","first-page":"8036","DOI":"10.1074\/jbc.M212127200","article-title":"GlcNAc 2-epimerase can serve a catabolic role in sialic acid metabolism","volume":"278","author":"Luchansky","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111243_bib111","doi-asserted-by":"crossref","first-page":"24313","DOI":"10.1074\/jbc.272.39.24313","article-title":"A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic acid biosynthesis of rat liver: purification and characterization of UDP-N-acetylglucosamine 2-epimerase\/N-acetylmannosamine kinase","volume":"272","author":"Hinderlich","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111243_bib112","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1021\/ja021309g","article-title":"Sialic acid biosynthesis: stereochemistry and mechanism of the reaction catalyzed by the mammalian UDP-N-acetylglucosamine 2-epimerase","volume":"125","author":"Chou","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2026.111243_bib113","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/128_2013_464","article-title":"UDP-GlcNAc 2-epimerase\/ManNAc kinase (GNE): a master regulator of sialic acid synthesis","volume":"366","author":"Hinderlich","year":"2015","journal-title":"Top. Curr. Chem."},{"key":"10.1016\/j.jbc.2026.111243_bib114","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/268462a0","article-title":"n-Butyrate causes histone modification in HeLa and friend erythroleukaemia cells","volume":"268","author":"Riggs","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111243_bib115","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/(SICI)1097-0290(19980620)58:6<642::AID-BIT10>3.0.CO;2-9","article-title":"Improvement of interferon-\u03b3 sialylation in Chinese hamster ovary cell culture by feeding of N-acetylmannosamine","volume":"58","author":"Gu","year":"1998","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jbc.2026.111243_bib116","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.chembiol.2006.09.016","article-title":"Targeting glycosylation pathways and the cell cycle: sugar- dependent activity of butyrate-carbohydrate cancer prodrugs","volume":"13","author":"Sampathkumar","year":"2006","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111243_bib117","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/bit.26560","article-title":"Butyrated ManNAc analog improves protein expression in Chinese hamster ovary cells","volume":"115","author":"Yin","year":"2018","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jbc.2026.111243_bib118","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri855","article-title":"Exosomes: composition, biogenesis and function","volume":"2","author":"Th\u00e9ry","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jbc.2026.111243_bib119","doi-asserted-by":"crossref","first-page":"3.22.21","DOI":"10.1002\/0471143030.cb0322s30","article-title":"Isolation and characterization of exosomes from cell culture supernatants and biological fluids","volume":"30","author":"Th\u00e9ry","year":"2006","journal-title":"Curr. Protoc. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111243_bib120","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.jbc.2026.111243_bib121","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0021-9258(18)52410-8","article-title":"Molecular cloning of the CD9 antigen. A new family of cell surface proteins","volume":"266","author":"Boucheix","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111243_bib122","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1016\/S0021-9258(18)49980-2","article-title":"CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells","volume":"266","author":"Metzelaar","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111243_bib123","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1096\/fj.201800664RR","article-title":"Cell surface CD63 increased by up-regulated polylactosamine modification sensitizes human melanoma cells to the BRAF inhibitor PLX4032","volume":"33","author":"Kudo","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.jbc.2026.111243_bib124","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1348-0421.2009.00167.x","article-title":"N-linked glycan-dependent interaction of CD63 with CXCR4 at the Golgi apparatus induces downregulation of CXCR4","volume":"53","author":"Yoshida","year":"2009","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.jbc.2026.111243_bib125","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/iub.2562","article-title":"Knockdown of ST6Gal-I expression in human hepatocellular carcinoma cells inhibits their exosome-mediated proliferation- and migration-promoting effects","volume":"73","author":"Wang","year":"2021","journal-title":"IUBMB Life"},{"key":"10.1016\/j.jbc.2026.111243_bib126","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/s41388-023-02702-w","article-title":"Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications","volume":"42","author":"Wang","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.111243_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108255","article-title":"Tetraspanin CD9 alters cellular trafficking and endocytosis of Tetraspanin CD63, affecting CD63 packaging into small extracellular vesicles","volume":"301","author":"Duke","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111243_bib128","doi-asserted-by":"crossref","first-page":"P634","DOI":"10.1016\/j.ymthe.2017.11.008","article-title":"The impact of the CD9 tetraspanin on lentivirus infectivity and exosome secretion","volume":"26","author":"B\u00f6ker","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jbc.2026.111243_bib129","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3389\/fimmu.2018.00863","article-title":"A key regulator of cell adhesion in the immune system","volume":"9","author":"Reyes","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2026.111243_bib130","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12082","article-title":"CD9 inhibition reveals a functional connection of extracellular vesicle secretion with mitophagy in melanoma cells","volume":"10","author":"Su\u00e1rez","year":"2021","journal-title":"J. Extracel. Vesicles"},{"key":"10.1016\/j.jbc.2026.111243_bib131","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s10620-008-0601-7","article-title":"Global histone H4 acetylation and HDAC2 expression in colon adenoma and carcinoma","volume":"54","author":"Ashktorab","year":"2009","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jbc.2026.111243_bib132","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molcel.2012.10.025","article-title":"Histone acetylation regulates intracellular pH","volume":"49","author":"McBrian","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2026.111243_bib133","article-title":"Acetylation of histone H3 in cancer progression and prognosis","volume":"49","author":"Miziak","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.111243_bib134","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/S0021-9258(18)52362-0","article-title":"Increased UDP-GlcNAc:Galb1-3GalNAc-R (GlcNAc to GalNAc) b-1, 6-N-acetylglucosaminyltransferase activity in metastatic murine tumor cell lines","volume":"266","author":"Yousefi","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111243_bib135","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1021\/pr401015b","article-title":"Common glycoproteins expressing polylactosamine-type glycans on matched patient primary and metastatic melanoma cells show different glycan profiles","volume":"13","author":"Kinoshita","year":"2013","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jbc.2026.111243_bib136","doi-asserted-by":"crossref","first-page":"10875","DOI":"10.7314\/APJCP.2014.15.24.10875","article-title":"B3GNT2, a polylactosamine synthase, regulates glycosylation of EGFR in H7721 human hepatocellular carcinoma cells","volume":"15","author":"Qiu","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.jbc.2026.111243_bib137","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/elps.200500510","article-title":"Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis","volume":"27","author":"Turhani","year":"2006","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jbc.2026.111243_bib138","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1021\/ol006054v","article-title":"A \u201ctraceless\u201d Staudinger ligation for the chemoselective synthesis of amide bonds","volume":"2","author":"Saxon","year":"2000","journal-title":"Org. Lett."},{"key":"10.1016\/j.jbc.2026.111243_bib139","doi-asserted-by":"crossref","DOI":"10.3390\/proteomes7020018","article-title":"Proteome profiling of exosomes purified from a small amount of human serum: the problem of co-purified serum components","volume":"7","author":"Smolarz","year":"2019","journal-title":"Proteomes"},{"key":"10.1016\/j.jbc.2026.111243_bib140","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1074\/mcp.M112.022806","article-title":"Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS","volume":"12","author":"Demory Beckler","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jbc.2026.111243_bib141","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ymeth.2015.04.008","article-title":"Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct","volume":"87","author":"Xu","year":"2015","journal-title":"Methods"},{"key":"10.1016\/j.jbc.2026.111243_bib142","doi-asserted-by":"crossref","first-page":"15375","DOI":"10.18632\/oncotarget.3801","article-title":"Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes","volume":"6","author":"Keerthikumar","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2026.111243_bib143","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/s41556-021-00805-8","article-title":"Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets","volume":"23","author":"Zhang","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111243_bib144","first-page":"2141","article-title":"Stratum corneum lipids, skin barrier function and filaagrin mutations in patients with atopic eczema","volume":"130","author":"Jungersted","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jbc.2026.111243_bib145","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000500402","article-title":"Genetics of atopic dermatitis: from DNA sequence to clinical relevance","volume":"235","author":"L\u00f8set","year":"2019","journal-title":"Dermatology"},{"key":"10.1016\/j.jbc.2026.111243_bib146","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/bjd.12969","article-title":"Filaggrin loss-of-function mutations and incident cancer: a population-based study","volume":"171","author":"Skaaby","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jbc.2026.111243_bib147","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.111243_bib148","article-title":"Excess filaggrin in keratinocytes is removed by extracellular vesicles to prevent premature death and this mechanism can be hijacked by Staphylococcus aureus in a TLR2-dependent fashion","volume":"12","author":"Bogucka","year":"2023","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.jbc.2026.111243_bib149","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12290","article-title":"Cell-specific targeting of extracellular vesicles through engineering the glycocalyx","volume":"11","author":"Zheng","year":"2022","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.jbc.2026.111243_bib150","doi-asserted-by":"crossref","first-page":"8166","DOI":"10.1074\/jbc.M114.621383","article-title":"Stabilization of exosome-targeting peptides via engineered glycosylation","volume":"290","author":"Hung","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111243_bib151","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.nbt.2024.07.004","article-title":"Cell-based glycoengineering of extracellular vesicles through precise genome editing","volume":"83","author":"Tian","year":"2024","journal-title":"New Biotechnol."},{"key":"10.1016\/j.jbc.2026.111243_bib152","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2020.1713527","article-title":"Altered biodistribution of deglycosylated extracellular vesicles through enhanced cellular uptake","volume":"9","author":"Nishida-Aoki","year":"2020","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.jbc.2026.111243_bib153","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1021\/acsami.4c20294","article-title":"Efficient enzymatic glycan engineering of extracellular vesicles using nanomaterial-interfaced microfluidics","volume":"17","author":"Zhou","year":"2025","journal-title":"ACS Appl. Mat. Inter."},{"key":"10.1016\/j.jbc.2026.111243_bib154","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202415942","article-title":"A new strategy to functionalize exosomes via enzymatic engineering of surface glycans and its application to profile exosomal glycans and endocytosis","volume":"12","author":"Kundu","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jbc.2026.111243_bib155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080580","article-title":"Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcina: applications in diagnosis and therapy","volume":"8","author":"Torres","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.111243_bib156","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/acs.bioconjchem.9b00161","article-title":"Extradomain-B fibronectin-targeted dextran-based chemical exchange saturation transfer magnetic resonance imaging for detecting pancreatic cancer","volume":"30","author":"Han","year":"2019","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jbc.2026.111243_bib157","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2016.00070","article-title":"An optimized approach to recover secreted proteins from fibroblast conditioned-media for secretomic analysis","volume":"10","author":"Par\u00e9","year":"2016","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.jbc.2026.111243_bib158","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1021\/ac025747h","article-title":"Empirical statistical model to estimate the accuracy of peptide identifications made by MS\/MS and database search","volume":"74","author":"Keller","year":"2002","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jbc.2026.111243_bib159","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1021\/ac0341261","article-title":"A statistical model for identifying proteins by tandem mass spectrometry","volume":"75","author":"Nesvizhskii","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jbc.2026.111243_bib160","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","author":"Consortium","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111243_bib161","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btz215","article-title":"SPRINT-Gly: predicting N-and O-linked glycosylation sites of human and mouse proteins by using sequence and predicted structural properties","volume":"35","author":"Taherzadeh","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jbc.2026.111243_bib162","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1021\/pr070446f","article-title":"Glycomics of proteoglycan biosynthesis in murine embryonic stem cell differentiation","volume":"6","author":"Nairn","year":"2007","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jbc.2026.111243_bib163","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0076-6879(10)79004-2","article-title":"Transcript analysis of stem cells","volume":"479","author":"Nairn","year":"2010","journal-title":"Meth. Enzymol."},{"key":"10.1016\/j.jbc.2026.111243_bib164","article-title":"Highly efficient magnetic labelling allows MRI tracking of the homing of stem cell-derived extracellular vesicles following systemic delivery","volume":"10","author":"Zheng","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.jbc.2026.111243_bib165","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70178","article-title":"Magnetically labelled iPSC-derived extracellular vesicles enable MRI\/MPI-guided regenerative therapy for myocardial infarction","volume":"14","author":"Wang","year":"2025","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.jbc.2026.111243_bib166","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12416","article-title":"MISEV2023: an updated guide to EV research and applications","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.jbc.2026.111243_bib167","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12079","article-title":"Characterization of extracellular vesicles and synthetic nanoparticles with four orthogonal single-particle analysis platforms","volume":"10","author":"Arab","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.jbc.2026.111243_bib168","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-57497-7","article-title":"A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum","volume":"10","author":"Brennan","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826001134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826001134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:36:11Z","timestamp":1776382571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826001134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":168,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0021925826001134"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111243","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profiling the pancreatic cancer secretome with metabolic glycoengineering","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"111243"}}